Author: So Young Kim; Weihua Jin; Amika Sood; David W. Montgomery; Oliver C. Grant; Mark M. Fuster; Li Fu; Jonathan S. Dordick; Robert J. Woods; Fuming Zhang; Robert J. Linhardt
Title: Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry Document date: 2020_4_15
ID: fs8dn7ir_28
Snippet: possess both GAG-binding and furin cleavage motifs at their S1/S2 junction in their SGPs [13] . In the cases of MHV and IBV spike proteins, a single amino acid mutation near the GAG-binding and furin cleavage motifs resulted from a cell culture adaptation, and determines whether a virion binds GAGs or exploits host cell surface protease, but not both [28] . While not within the CoV family, human immunodeficiency virus type 1 (HIV-1) requires HS-b.....
Document: possess both GAG-binding and furin cleavage motifs at their S1/S2 junction in their SGPs [13] . In the cases of MHV and IBV spike proteins, a single amino acid mutation near the GAG-binding and furin cleavage motifs resulted from a cell culture adaptation, and determines whether a virion binds GAGs or exploits host cell surface protease, but not both [28] . While not within the CoV family, human immunodeficiency virus type 1 (HIV-1) requires HS-binding to achieve optimal furin processing because HS binding allows selective exposure of furin cleavage site [29] . While the idea of repurposing HP as COVID-19 therapeutic sounds appealing, further questions, including in vitro relevance of GAGs as host cell surface receptors, proteolytic processing of SGPs at S1/S2 junction, and their relationship in host cell entry and infectivity, must first be carefully evaluated.
Search related documents:
Co phrase search for related documents- host cell surface and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7
- host cell surface and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- host cell surface protease and spike protein: 1, 2, 3, 4
- host cell surface receptor and HS bind: 1
- host cell surface receptor and human immunodeficiency: 1
- host cell surface receptor and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- host cell surface receptor and virus type: 1, 2
- HS bind and proteolytic processing: 1, 2
- HS bind and spike protein: 1, 2, 3, 4, 5
- HS bind and virus type: 1, 2
- human immunodeficiency and infectivity host cell entry: 1
- human immunodeficiency and proteolytic processing: 1, 2, 3, 4
- human immunodeficiency and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- human immunodeficiency and virus type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- infectivity host cell entry and spike protein: 1
- optimal furin processing and selective exposure: 1
- proteolytic processing and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- proteolytic processing and virus type: 1, 2, 3, 4, 5, 6, 7
- selective exposure and spike protein: 1, 2
Co phrase search for related documents, hyperlinks ordered by date